Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Non-cash Items (2019 - 2024)

Historic Non-cash Items for Capricor Therapeutics (CAPR) over the last 8 years, with Q4 2024 value amounting to $101.8 million.

  • Capricor Therapeutics' Non-cash Items rose 65398.13% to $101.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $101.8 million, marking a year-over-year increase of 65398.13%. This contributed to the annual value of $101.8 million for FY2024, which is 65398.13% up from last year.
  • Per Capricor Therapeutics' latest filing, its Non-cash Items stood at $101.8 million for Q4 2024, which was up 65398.13% from $16.6 million recorded in Q3 2024.
  • Capricor Therapeutics' 5-year Non-cash Items high stood at $101.8 million for Q4 2024, and its period low was $171000.0 during Q1 2020.
  • Over the past 5 years, Capricor Therapeutics' median Non-cash Items value was $12.0 million (recorded in 2022), while the average stood at $15.0 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first crashed by 7049.19% in 2020, then skyrocketed by 487076.02% in 2021.
  • Over the past 5 years, Capricor Therapeutics' Non-cash Items (Quarter) stood at $4.2 million in 2020, then soared by 81.74% to $7.7 million in 2021, then surged by 31.17% to $10.1 million in 2022, then skyrocketed by 33.66% to $13.5 million in 2023, then skyrocketed by 653.98% to $101.8 million in 2024.
  • Its Non-cash Items was $101.8 million in Q4 2024, compared to $16.6 million in Q3 2024 and $19.2 million in Q2 2024.